BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Horvath AR, Lord SJ, StJohn A, Sandberg S, Cobbaert CM, Lorenz S, Monaghan PJ, Verhagen-Kamerbeek WD, Ebert C, Bossuyt PM. From biomarkers to medical tests: the changing landscape of test evaluation. Clin Chim Acta. 2014;427:49-57. [PMID: 24076255 DOI: 10.1016/j.cca.2013.09.018] [Cited by in Crossref: 100] [Cited by in F6Publishing: 85] [Article Influence: 11.1] [Reference Citation Analysis]
Number Citing Articles
1 Millard RW, Tranter M. Biomarcadores no troponínicos, complementarios, alternativos y presuntos, para el síndrome coronario agudo: nuevos recursos para los futuros instrumentos de cálculo del riesgo. Revista Española de Cardiología 2014;67:312-20. [DOI: 10.1016/j.recesp.2013.12.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
2 Kessel C, McArdle A, Verweyen E, Weinhage T, Wittkowski H, Pennington SR, Foell D. Proteomics in Chronic Arthritis-Will We Finally Have Useful Biomarkers? Curr Rheumatol Rep 2018;20:53. [PMID: 30008153 DOI: 10.1007/s11926-018-0762-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Horgan D, Ciliberto G, Conte P, Baldwin D, Seijo L, Montuenga LM, Paz-Ares L, Garassino M, Penault-Llorca F, Galli F, Ray-Coquard I, Querleu D, Capoluongo E, Banerjee S, Riegman P, Kerr K, Horbach B, Büttner R, Van Poppel H, Bjartell A, Codacci-Pisanelli G, Westphalen B, Calvo F, Koeva-Balabanova J, Hall S, Paradiso A, Kalra D, Cobbaert C, Varea Menendez R, Maravic Z, Fotaki V, Bennouna J, Cauchin E, Malats N, Gutiérrez-Ibarluzea I, Gannon B, Mastris K, Bernini C, Gallagher W, Buglioni S, Kent A, Munzone E, Belina I, Van Meerbeeck J, Duffy M, Sarnowska E, Jagielska B, Mee S, Curigliano G. Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology. Biomed Hub 2020;5:182-223. [PMID: 33564664 DOI: 10.1159/000511209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 de Graaf G, Postmus D, Westerink J, Buskens E. The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications. Cost Eff Resour Alloc 2018;16:23. [PMID: 29946228 DOI: 10.1186/s12962-018-0105-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Walter FM, Thompson MJ, Wellwood I, Abel GA, Hamilton W, Johnson M, Lyratzopoulos G, Messenger MP, Neal RD, Rubin G, Singh H, Spencer A, Sutton S, Vedsted P, Emery JD. Evaluating diagnostic strategies for early detection of cancer: the CanTest framework. BMC Cancer 2019;19:586. [PMID: 31200676 DOI: 10.1186/s12885-019-5746-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
6 Ahmad E, Ali A, Nimisha, Kumar Sharma A, Apurva, Kumar A, Mehdi G, Sumayya Abdul Sattar R, Verma R, Mahajan B, Singh Saluja S. Molecular markers in cancer. Clinica Chimica Acta 2022. [DOI: 10.1016/j.cca.2022.05.029] [Reference Citation Analysis]
7 Cobbaert CM, Arslan F, Caballé Martín I, Serra AA, Picó-Plana E, Sánchez-Margalet V, Carmona-Fernández A, Burden J, Ziegler A, Bechel W. Automated urinalysis combining physicochemical analysis, on-board centrifugation, and digital imaging in one system: A multicenter performance evaluation of the cobas 6500 urine work area. Pract Lab Med 2019;17:e00139. [PMID: 31649991 DOI: 10.1016/j.plabm.2019.e00139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Gopalakrishna G, Leeflang MM, Davenport C, Sanabria AJ, Alonso-Coello P, McCaffery K, Bossuyt P, Langendam MW. Barriers to making recommendations about medical tests: a qualitative study of European guideline developers. BMJ Open 2016;6:e010549. [PMID: 27638490 DOI: 10.1136/bmjopen-2015-010549] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Kip MM, Steuten LM, Koffijberg H, IJzerman MJ, Kusters R. Using expert elicitation to estimate the potential impact of improved diagnostic performance of laboratory tests: a case study on rapid discharge of suspected non-ST elevation myocardial infarction patients. J Eval Clin Pract 2018;24:31-41. [PMID: 27761961 DOI: 10.1111/jep.12626] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
10 van Duijl TT, Ruhaak LR, de Fijter JW, Cobbaert CM. Kidney Injury Biomarkers in an Academic Hospital Setting: Where Are We Now? Clin Biochem Rev 2019;40:79-97. [PMID: 31205376 DOI: 10.33176/AACB-18-00017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Howick J, Bossuyt PM, Cals JWL. Point of care testing in family practice: common myths debunked. FAMPRJ. [DOI: 10.1093/fampra/cmw082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Holtman GA, Berger MY, Burger H, Deeks JJ, Donner-Banzhoff N, Fanshawe TR, Koshiaris C, Leeflang MM, Oke JL, Perera R, Reitsma JB, Van den Bruel A. Development of practical recommendations for diagnostic accuracy studies in low-prevalence situations. J Clin Epidemiol 2019;114:38-48. [PMID: 31150837 DOI: 10.1016/j.jclinepi.2019.05.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Verbakel JY, Turner PJ, Thompson MJ, Plüddemann A, Price CP, Shinkins B, Van den Bruel A. Common evidence gaps in point-of-care diagnostic test evaluation: a review of horizon scan reports. BMJ Open 2017;7:e015760. [PMID: 28864692 DOI: 10.1136/bmjopen-2016-015760] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
14 Millard RW, Tranter M. Complementary, alternative, and putative nontroponin biomarkers of acute coronary syndrome: new resources for future risk assessment calculators. Rev Esp Cardiol (Engl Ed) 2014;67:312-20. [PMID: 24774594 DOI: 10.1016/j.rec.2013.12.011] [Reference Citation Analysis]
15 Díaz-Fernández A, Lorenzo-Gómez R, Miranda-Castro R, de-Los-Santos-Álvarez N, Lobo-Castañón MJ. Electrochemical aptasensors for cancer diagnosis in biological fluids - A review. Anal Chim Acta 2020;1124:1-19. [PMID: 32534661 DOI: 10.1016/j.aca.2020.04.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
16 Ruhaak LR, Romijn FPHTM, Smit NPM, van der Laarse A, Pieterse MM, de Maat MPM, Haas FJLM, Kluft C, Amiral J, Meijer P, Cobbaert CM. Detecting molecular forms of antithrombin by LC-MRM-MS: defining the measurands. Clin Chem Lab Med 2018;56:1704-14. [PMID: 29708875 DOI: 10.1515/cclm-2017-1111] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
17 Guo J, Liu Y, Ju H, Lu G. From lab to field: Surface-enhanced Raman scattering-based sensing strategies for on-site analysis. TrAC Trends in Analytical Chemistry 2022;146:116488. [DOI: 10.1016/j.trac.2021.116488] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
18 Jülicher P, O'Kane M, Price CP, Christenson R, John AS. Health economic evaluations of medical tests: Translating laboratory information into value - A case study example. Ann Clin Biochem 2021;:45632211013852. [PMID: 33874738 DOI: 10.1177/00045632211013852] [Reference Citation Analysis]
19 Langlois MR, Nordestgaard BG, Langsted A, Chapman MJ, Aakre KM, Baum H, Borén J, Bruckert E, Catapano A, Cobbaert C, Collinson P, Descamps OS, Duff CJ, von Eckardstein A, Hammerer-Lercher A, Kamstrup PR, Kolovou G, Kronenberg F, Mora S, Pulkki K, Remaley AT, Rifai N, Ros E, Stankovic S, Stavljenic-Rukavina A, Sypniewska G, Watts GF, Wiklund O, Laitinen P; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM. Clin Chem Lab Med 2020;58:496-517. [PMID: 31855562 DOI: 10.1515/cclm-2019-1253] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 27.0] [Reference Citation Analysis]
20 Takwoingi Y, Partlett C, Riley RD, Hyde C, Deeks JJ. Methods and reporting of systematic reviews of comparative accuracy were deficient: a methodological survey and proposed guidance. J Clin Epidemiol 2020;121:1-14. [PMID: 31843693 DOI: 10.1016/j.jclinepi.2019.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 Raths S, Parkel S, Bredmose J, Daussin V. Mind the gap! A survey of the challenges of biomarker commercialization. Drug Discovery Today 2020;25:22-6. [DOI: 10.1016/j.drudis.2019.09.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Smit NPM, Ruhaak LR, Romijn FPHTM, Pieterse MM, van der Burgt YEM, Cobbaert CM. The Time Has Come for Quantitative Protein Mass Spectrometry Tests That Target Unmet Clinical Needs. J Am Soc Mass Spectrom 2021;32:636-47. [PMID: 33522792 DOI: 10.1021/jasms.0c00379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Ioannidis JPA, Bossuyt PMM. Waste, Leaks, and Failures in the Biomarker Pipeline. Clinical Chemistry 2017;63:963-72. [DOI: 10.1373/clinchem.2016.254649] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 16.0] [Reference Citation Analysis]
24 van Duijl TT, Soonawala D, de Fijter JW, Ruhaak LR, Cobbaert CM. Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury. Clin Proteomics 2021;18:10. [PMID: 33618665 DOI: 10.1186/s12014-021-09315-z] [Reference Citation Analysis]
25 Langlois MR, Chapman MJ, Cobbaert C, Mora S, Remaley AT, Ros E, Watts GF, Borén J, Baum H, Bruckert E, Catapano A, Descamps OS, von Eckardstein A, Kamstrup PR, Kolovou G, Kronenberg F, Langsted A, Pulkki K, Rifai N, Sypniewska G, Wiklund O, Nordestgaard BG; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative. Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM. Clin Chem 2018;64:1006-33. [PMID: 29760220 DOI: 10.1373/clinchem.2018.287037] [Cited by in Crossref: 105] [Cited by in F6Publishing: 79] [Article Influence: 26.3] [Reference Citation Analysis]
26 Loh TP, Lord SJ, Bell K, Bohn MK, Lim CY, Markus C, Fares Taie H, Adeli K, Lippi G, Sandberg S, Horvath A. Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing. Clin Biochem 2021;88:18-22. [PMID: 33227233 DOI: 10.1016/j.clinbiochem.2020.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Giusepi I, John AS, Jülicher P. Who Conducts Health Economic Evaluations of Laboratory Tests? A Scoping Review. The Journal of Applied Laboratory Medicine 2020;5:954-66. [DOI: 10.1093/jalm/jfaa107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Badrick T. Biological variation: Understanding why it is so important? Pract Lab Med 2021;23:e00199. [PMID: 33490349 DOI: 10.1016/j.plabm.2020.e00199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Sajid I, Parkunan A, Frost K. Unintended Consequences: An Evaluation Quantifying Benefits, Iatrogenic Harms and Downstream Cascade Costs of Musculoskeletal Magnetic Resonance Imaging (MRI) in UK Primary Care. SSRN Journal. [DOI: 10.2139/ssrn.3735015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Cobbaert C. Time for a holistic approach and standardization education in laboratory medicine. Clinical Chemistry and Laboratory Medicine (CCLM) 2017;55. [DOI: 10.1515/cclm-2016-0952] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
31 Selby PJ, Banks RE, Gregory W, Hewison J, Rosenberg W, Altman DG, Deeks JJ, Mccabe C, Parkes J, Sturgeon C, Thompson D, Twiddy M, Bestall J, Bedlington J, Hale T, Dinnes J, Jones M, Lewington A, Messenger MP, Napp V, Sitch A, Tanwar S, Vasudev NS, Baxter P, Bell S, Cairns DA, Calder N, Corrigan N, Del Galdo F, Heudtlass P, Hornigold N, Hulme C, Hutchinson M, Lippiatt C, Livingstone T, Longo R, Potton M, Roberts S, Sim S, Trainor S, Welberry Smith M, Neuberger J, Thorburn D, Richardson P, Christie J, Sheerin N, Mckane W, Gibbs P, Edwards A, Soomro N, Adeyoju A, Stewart GD, Hrouda D. Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT. Programme Grants Appl Res 2018;6:1-528. [DOI: 10.3310/pgfar06030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
32 Kilpatrick ES, Sandberg S. An overview of EFLM harmonization activities in Europe. Clin Chem Lab Med 2018;56:1591-7. [PMID: 29924732 DOI: 10.1515/cclm-2018-0098] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Corbacho-Alonso N, Rodríguez-Sánchez E, Martin-Rojas T, Mouriño-Alvarez L, Sastre-Oliva T, Hernandez-Fernandez G, Padial LR, Ruilope LM, Ruiz-Hurtado G, Barderas MG. Proteomic investigations into hypertension: what's new and how might it affect clinical practice? Expert Rev Proteomics 2019;16:583-91. [PMID: 31195841 DOI: 10.1080/14789450.2019.1632197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Keitel K, D'Acremont V. Electronic clinical decision algorithms for the integrated primary care management of febrile children in low-resource settings: review of existing tools. Clin Microbiol Infect 2018;24:845-55. [PMID: 29684634 DOI: 10.1016/j.cmi.2018.04.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
35 Lubbers BR, Schilhabel A, Cobbaert CM, Gonzalez D, Dombrink I, Brüggemann M, Bitter WM, van Dongen JJM. The New EU Regulation on In Vitro Diagnostic Medical Devices: Implications and Preparatory Actions for Diagnostic Laboratories. Hemasphere 2021;5:e568. [PMID: 33898932 DOI: 10.1097/HS9.0000000000000568] [Reference Citation Analysis]
36 Duffy MJ, Sturgeon CM, Sölétormos G, Barak V, Molina R, Hayes DF, Diamandis EP, Bossuyt PM. Validation of new cancer biomarkers: a position statement from the European group on tumor markers. Clin Chem 2015;61:809-20. [PMID: 25882892 DOI: 10.1373/clinchem.2015.239863] [Cited by in Crossref: 91] [Cited by in F6Publishing: 60] [Article Influence: 13.0] [Reference Citation Analysis]
37 Moshi MR, Parsons J, Tooher R, Merlin T. Evaluation of Mobile Health Applications: Is Regulatory Policy Up to the Challenge? Int J Technol Assess Health Care 2019;35:351-60. [PMID: 31307566 DOI: 10.1017/S0266462319000461] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
38 Renee Ruhaak L, van der Laarse A, Cobbaert CM. Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia. Ann Clin Biochem 2019;56:338-56. [PMID: 30889974 DOI: 10.1177/0004563219827620] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
39 Monaghan PJ, Bossuyt PM. Test evaluation: major challengesahead - Opportunities abound. Ann Clin Biochem 2019;56:524-6. [PMID: 30971105 DOI: 10.1177/0004563219837301] [Reference Citation Analysis]
40 Olsen M, Fischer K, Bossuyt PM, Goetghebeur E. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification. BMC Cancer 2021;21:1351. [PMID: 34930164 DOI: 10.1186/s12885-021-08937-8] [Reference Citation Analysis]
41 Orth M, Averina M, Chatzipanagiotou S, Faure G, Haushofer A, Kusec V, Machado A, Misbah SA, Oosterhuis W, Pulkki K, Twomey PJ, Wieland E. Opinion: redefining the role of the physician in laboratory medicine in the context of emerging technologies, personalised medicine and patient autonomy ('4P medicine'). J Clin Pathol 2019;72:191-7. [PMID: 29273576 DOI: 10.1136/jclinpath-2017-204734] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
42 Ruhaak LR, van der Burgt YE, Cobbaert CM. Prospective applications of ultrahigh resolution proteomics in clinical mass spectrometry. Expert Review of Proteomics 2016;13:1063-71. [DOI: 10.1080/14789450.2016.1253477] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
43 Hallworth MJ, Epner PL, Ebert C, Fantz CR, Faye SA, Higgins TN, Kilpatrick ES, Li W, Rana SV, Vanstapel F. Current Evidence and Future Perspectives on the Effective Practice of Patient-Centered Laboratory Medicine. Clinical Chemistry 2015;61:589-99. [DOI: 10.1373/clinchem.2014.232629] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
44 Ansems S, Berger M, Rheenen PV, Vermeulen K, Beugel G, Couwenberg M, Holtman G. Effect of faecal calprotectin testing on referrals for children with chronic gastrointestinal symptoms in primary care: study protocol for a cluster randomised controlled trial. BMJ Open 2021;11:e045444. [PMID: 34301652 DOI: 10.1136/bmjopen-2020-045444] [Reference Citation Analysis]
45 Briers PJ, Langlois MR. Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol. Biochem Med (Zagreb) 2022;32:010704. [PMID: 34955672 DOI: 10.11613/BM.2022.010704] [Reference Citation Analysis]
46 Van den Bruel A, Hayward G. Diagnostic evidence cooperatives: bridging the valley of death in diagnostics development. Diagn Progn Res 2018;2:9. [PMID: 31093559 DOI: 10.1186/s41512-018-0030-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Bossuyt PM. Testing COVID-19 tests faces methodological challenges. J Clin Epidemiol 2020;126:172-6. [PMID: 32622902 DOI: 10.1016/j.jclinepi.2020.06.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
48 Sakkas D, Ramalingam M, Garrido N, Barratt CL. Sperm selection in natural conception: what can we learn from Mother Nature to improve assisted reproduction outcomes? Hum Reprod Update 2015;21:711-26. [PMID: 26386468 DOI: 10.1093/humupd/dmv042] [Cited by in Crossref: 93] [Cited by in F6Publishing: 78] [Article Influence: 13.3] [Reference Citation Analysis]
49 Sajid IM, Frost K, Paul AK. 'Diagnostic downshift': clinical and system consequences of extrapolating secondary care testing tactics to primary care. BMJ Evid Based Med 2021:bmjebm-2020-111629. [PMID: 34099498 DOI: 10.1136/bmjebm-2020-111629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Nordestgaard BG, Langlois MR, Langsted A, Chapman MJ, Aakre KM, Baum H, Borén J, Bruckert E, Catapano A, Cobbaert C, Collinson P, Descamps OS, Duff CJ, von Eckardstein A, Hammerer-lercher A, Kamstrup PR, Kolovou G, Kronenberg F, Mora S, Pulkki K, Remaley AT, Rifai N, Ros E, Stankovic S, Stavljenic-rukavina A, Sypniewska G, Watts GF, Wiklund O, Laitinen P. Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM. Atherosclerosis 2020;294:46-61. [DOI: 10.1016/j.atherosclerosis.2019.12.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 17.5] [Reference Citation Analysis]
51 Ruhaak L, Cobbaert C. Quantifying apolipoprotein(a) in the era of proteoforms and precision medicine. Clinica Chimica Acta 2020;511:260-8. [DOI: 10.1016/j.cca.2020.10.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
52 Sajid IM, Parkunan A, Frost K. Unintended consequences: quantifying the benefits, iatrogenic harms and downstream cascade costs of musculoskeletal MRI in UK primary care. BMJ Open Qual 2021;10:e001287. [PMID: 34215659 DOI: 10.1136/bmjoq-2020-001287] [Reference Citation Analysis]
53 Hallworth MJ. Improving clinical outcomes - towards patient-centred laboratory medicine. Ann Clin Biochem 2015;52:715-6. [PMID: 26113738 DOI: 10.1177/0004563215595431] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
54 Marks H, Schechinger M, Garza J, Locke A, Coté G. Surface enhanced Raman spectroscopy (SERS) for in vitro diagnostic testing at the point of care. Nanophotonics 2017;6:681-701. [DOI: 10.1515/nanoph-2016-0180] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 6.2] [Reference Citation Analysis]
55 van der Burgt YEM, Cobbaert CM. Proteoform Analysis to Fulfill Unmet Clinical Needs and Reach Global Standardization of Protein Measurands in Clinical Chemistry Proteomics. Clin Lab Med 2018;38:487-97. [PMID: 30115393 DOI: 10.1016/j.cll.2018.05.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
56 Pu Q, Yang X, Guo Y, Dai T, Yang T, Ou X, Li J, Sheng S, Xie G. Simultaneous colorimetric determination of acute myocardial infarction biomarkers by integrating self-assembled 3D gold nanovesicles into a multiple immunosorbent assay. Microchim Acta 2019;186. [DOI: 10.1007/s00604-019-3242-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
57 van der Burgt YEM, Siliakus KM, Cobbaert CM, Ruhaak LR. HILIC-MRM-MS for Linkage-Specific Separation of Sialylated Glycopeptides to Quantify Prostate-Specific Antigen Proteoforms. J Proteome Res 2020;19:2708-16. [PMID: 32142289 DOI: 10.1021/acs.jproteome.0c00050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
58 Francis NA, Gillespie D, White P, Bates J, Lowe R, Sewell B, Phillips R, Stanton H, Kirby N, Wootton M, Thomas-Jones E, Hood K, Llor C, Cals J, Melbye H, Naik G, Gal M, Fitzsimmons D, Alam MF, Riga E, Cochrane A, Butler CC. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT. Health Technol Assess 2020;24:1-108. [PMID: 32202490 DOI: 10.3310/hta24150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
59 Ruhaak LR, Smit NPM, Romijn FPHTM, Pieterse MM, van der Laarse A, van der Burgt YEM, Cobbaert CM. Robust and Accurate 2-Year Performance of a Quantitative Mass Spectrometry-Based Apolipoprotein Test in a Clinical Chemistry Laboratory. Clin Chem 2018;64:747-9. [PMID: 29378689 DOI: 10.1373/clinchem.2017.285098] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
60 Pennestrì F, Banfi G. Value-based healthcare: the role of laboratory medicine. Clin Chem Lab Med 2019;57:798-801. [PMID: 30738014 DOI: 10.1515/cclm-2018-1245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
61 Takwoingi Y, Quinn TJ. Review of Diagnostic Test Accuracy (DTA) studies in older people. Age Ageing 2018;47:349-55. [PMID: 29528366 DOI: 10.1093/ageing/afy023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
62 Ghannad M, Olsen M, Boutron I, Bossuyt PM. A systematic review finds that spin or interpretation bias is abundant in evaluations of ovarian cancer biomarkers. Journal of Clinical Epidemiology 2019;116:9-17. [DOI: 10.1016/j.jclinepi.2019.07.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
63 Schmidt RL, Straseski JA, Raphael KL, Adams AH, Lehman CM. A Risk Assessment of the Jaffe vs Enzymatic Method for Creatinine Measurement in an Outpatient Population. PLoS One. 2015;10:e0143205. [PMID: 26599086 DOI: 10.1371/journal.pone.0143205] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
64 Butler CC, Francis NA, Thomas-Jones E, Longo M, Wootton M, Llor C, Little P, Moore M, Bates J, Pickles T, Kirby N, Gillespie D, Rumsby K, Brugman C, Gal M, Hood K, Verheij T. Point-of-care urine culture for managing urinary tract infection in primary care: a randomised controlled trial of clinical and cost-effectiveness. Br J Gen Pract 2018;68:e268-78. [PMID: 29483078 DOI: 10.3399/bjgp18X695285] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
65 Franier BDL, Thompson M. Early stage detection and screening of ovarian cancer: A research opportunity and significant challenge for biosensor technology. Biosensors and Bioelectronics 2019;135:71-81. [DOI: 10.1016/j.bios.2019.03.041] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
66 Bossuyt PM, Olsen M, Hyde C, Cohen JF. An analysis reveals differences between pragmatic and explanatory diagnostic accuracy studies. J Clin Epidemiol 2020;117:29-35. [PMID: 31561014 DOI: 10.1016/j.jclinepi.2019.09.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
67 Lovrenčić MV, Biljak VR, Blaslov K, Božičević S, Duvnjak LS. Impact of creatinine methodology on glomerular filtration rate estimation in diabetes. World J Diabetes 2017; 8(5): 222-229 [PMID: 28572883 DOI: 10.4239/wjd.v8.i5.222] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
68 Langlois MR. Investigations on the clinical utility of apolipoprotein B measurement: A research priority. Eur J Prev Cardiol 2020;27:1252-4. [PMID: 31403883 DOI: 10.1177/2047487319869578] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 van Lint CL, van der Boog PJ, Wang W, Brinkman WP, Rövekamp TJ, Neerincx MA, Rabelink TJ, van Dijk S. Patient experiences with self-monitoring renal function after renal transplantation: results from a single-center prospective pilot study. Patient Prefer Adherence. 2015;9:1721-1731. [PMID: 26673985 DOI: 10.2147/ppa.s92108] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
70 Olsen M, Ghannad M, Lok C, Bossuyt PM. Shortcomings in the evaluation of biomarkers in ovarian cancer: a systematic review. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;58:3-10. [DOI: 10.1515/cclm-2019-0038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
71 St John A, Cullen L, Jülicher P, Price CP. Developing a value proposition for high-sensitivity troponin testing. Clinica Chimica Acta 2018;477:154-9. [DOI: 10.1016/j.cca.2017.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
72 Simons JE, Don-wauchope AC. Evaluation of natriuretic peptide recommendations in heart failure clinical practice guidelines. Clinical Biochemistry 2016;49:8-15. [DOI: 10.1016/j.clinbiochem.2015.08.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
73 Critselis E, Lambers Heerspink H. Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression. Nephrol Dial Transplant. 2016;31:249-254. [PMID: 25791724 DOI: 10.1093/ndt/gfv062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
74 Mischak H, Critselis E, Hanash S, Gallagher WM, Vlahou A, Ioannidis JP. Epidemiologic design and analysis for proteomic studies: a primer on -omic technologies. Am J Epidemiol 2015;181:635-47. [PMID: 25792606 DOI: 10.1093/aje/kwu462] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
75 Cocco P, Ayaz-Shah A, Messenger MP, West RM, Shinkins B. Target Product Profiles for medical tests: a systematic review of current methods. BMC Med 2020;18:119. [PMID: 32389127 DOI: 10.1186/s12916-020-01582-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
76 Smit NP, Romijn FP, van den Broek I, Drijfhout JW, Haex M, van der Laarse A, van der Burgt YE, Cobbaert CM. Metrological traceability in mass spectrometry-based targeted protein quantitation: a proof-of-principle study for serum apolipoproteins A-I and B100. J Proteomics 2014;109:143-61. [PMID: 24972322 DOI: 10.1016/j.jprot.2014.06.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
77 de Haan N, Wuhrer M, Ruhaak LR. Mass spectrometry in clinical glycomics: The path from biomarker identification to clinical implementation. Clin Mass Spectrom 2020;18:1-12. [PMID: 34820521 DOI: 10.1016/j.clinms.2020.08.001] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Kavsak PA, Edge T, Roy C, Malinowski P, Bamford K, Clark L, Lamers S, Hill S, Worster A. Analytical assessment of ortho clinical diagnostics high-sensitivity cardiac troponin I assay. Clin Chem Lab Med 2020:cclm-2020-1115. [PMID: 33079697 DOI: 10.1515/cclm-2020-1115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
79 Monaghan PJ, Lord SJ, St John A, Sandberg S, Cobbaert CM, Lennartz L, Verhagen-Kamerbeek WD, Ebert C, Bossuyt PM, Horvath AR; Test Evaluation Working Group of the European Federation of Clinical Chemistry and Laboratory Medicine. Biomarker development targeting unmet clinical needs. Clin Chim Acta 2016;460:211-9. [PMID: 27374304 DOI: 10.1016/j.cca.2016.06.037] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
80 Hirst JA, Farmer AJ, Williams V. How point-of-care HbA1c testing changes the behaviour of people with diabetes and clinicians - a qualitative study. Diabet Med 2020;37:1008-15. [PMID: 31876039 DOI: 10.1111/dme.14219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
81 de Hond AAH, van Calster B, Steyerberg EW. Commentary: Artificial Intelligence and Statistics: Just the Old Wine in New Wineskins? Front Digit Health 2022;4:923944. [DOI: 10.3389/fdgth.2022.923944] [Reference Citation Analysis]
82 Critselis E, Vlahou A, Stel VS, Morton RL. Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion. Nephrology Dialysis Transplantation 2018;33:441-9. [DOI: 10.1093/ndt/gfx068] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
83 Dirks NF, Ackermans MT, Martens F, Cobbaert CM, de Jonge R, Heijboer AC. We need to talk about the analytical performance of our laboratory developed clinical LC-MS/MS tests, and start separating the wheat from the chaff. Clin Chim Acta 2021;514:80-3. [PMID: 33359058 DOI: 10.1016/j.cca.2020.12.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Bates J, Francis NA, White P, Gillespie D, Thomas-Jones E, Breen R, Kirby N, Hood K, Gal M, Phillips R, Naik G, Cals J, Llor C, Melbye H, Wootton M, Riga E, Cochrane A, Howe R, Fitzsimmons D, Sewell B, Alam MF, Butler CC. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial. Trials 2017;18:442. [PMID: 28969667 DOI: 10.1186/s13063-017-2144-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
85 Hogarth S, Miller FA, Sturdy S. Multidisciplinary perspectives on the regulation of diagnostic technologies. Soc Sci Med 2022;304:115059. [PMID: 35715015 DOI: 10.1016/j.socscimed.2022.115059] [Reference Citation Analysis]
86 Lord SJ, St John A, Bossuyt PM, Sandberg S, Monaghan PJ, O'Kane M, Cobbaert CM, Röddiger R, Lennartz L, Gelfi C, Horvath AR; Test Evaluation Working Group of the European Federation of Clinical Chemistry and Laboratory Medicine. Setting clinical performance specifications to develop and evaluate biomarkers for clinical use. Ann Clin Biochem 2019;56:527-35. [PMID: 30987429 DOI: 10.1177/0004563219842265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
87 Tebani A, Afonso C, Marret S, Bekri S. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations. Int J Mol Sci 2016;17:E1555. [PMID: 27649151 DOI: 10.3390/ijms17091555] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 13.0] [Reference Citation Analysis]
88 St John A, Edwards G, Fisher S, Badrick T, Callahan J, Crothers J. A call for a value based approach to laboratory medicine funding. Clinical Biochemistry 2015;48:823-6. [DOI: 10.1016/j.clinbiochem.2015.07.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
89 Bergmann K, Sypniewska G. Secreted frizzled-related protein 4 (SFRP4) and fractalkine (CX3CL1) — Potential new biomarkers for β-cell dysfunction and diabetes. Clinical Biochemistry 2014;47:529-32. [DOI: 10.1016/j.clinbiochem.2014.03.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
90 Lehmann S, Brede C, Lescuyer P, Cocho JA, Vialaret J, Bros P, Delatour V, Hirtz C. Clinical mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold? Clinica Chimica Acta 2017;467:51-8. [DOI: 10.1016/j.cca.2016.06.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
91 Trenti T, Plebani M. Diagnostic test accuracy: a valuable tool for promoting quality and patient safety. Diagnosis (Berl) 2018;5:175-8. [PMID: 30307895 DOI: 10.1515/dx-2018-0091] [Reference Citation Analysis]
92 Li E, Dewez JE, Luu Q, Emonts M, Maconochie I, Nijman R, Yeung S. Role of point-of-care tests in the management of febrile children: a qualitative study of hospital-based doctors and nurses in England. BMJ Open 2021;11:e044510. [PMID: 33972339 DOI: 10.1136/bmjopen-2020-044510] [Reference Citation Analysis]
93 Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, Irwig L, Levine D, Reitsma JB, de Vet HC. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6:e012799. [PMID: 28137831 DOI: 10.1136/bmjopen-2016-012799] [Cited by in Crossref: 629] [Cited by in F6Publishing: 569] [Article Influence: 104.8] [Reference Citation Analysis]
94 Ferraro S, Biganzoli EM, Castaldi S, Plebani M. Health Technology Assessment to assess value of biomarkers in the decision-making process. Clin Chem Lab Med 2022. [PMID: 35245972 DOI: 10.1515/cclm-2021-1291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Schmidt RL, Factor RE. What Does it Mean for a Recommendation to be Evidence-Based? Lab Med 2019;50:5-7. [PMID: 30576520 DOI: 10.1093/labmed/lmy071] [Reference Citation Analysis]
96 St John A. The Pursuit of Value in Laboratory Medicine - Progress and Challenges. Clin Biochem Rev 2020;41:3-11. [PMID: 32158058 DOI: 10.33176/AACB-19-00035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]